Literature DB >> 22487705

Glomerular disease: Eculizumab for the treatment of MPGN.

Susan J Allison.   

Abstract

Entities:  

Year:  2012        PMID: 22487705     DOI: 10.1038/nrneph.2012.72

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  3 in total

1.  Eculizumab and refractory membranoproliferative glomerulonephritis.

Authors:  Seetha Radhakrishnan; Andrew Lunn; Michael Kirschfink; Paul Thorner; Diane Hebert; Valerie Langlois; Fred Pluthero; Christoph Licht
Journal:  N Engl J Med       Date:  2012-03-22       Impact factor: 91.245

2.  Eculizumab for the treatment of dense-deposit disease.

Authors:  Marina Vivarelli; Andrea Pasini; Francesco Emma
Journal:  N Engl J Med       Date:  2012-03-22       Impact factor: 91.245

3.  Eculizumab in a patient with dense-deposit disease.

Authors:  Erica Daina; Marina Noris; Giuseppe Remuzzi
Journal:  N Engl J Med       Date:  2012-03-22       Impact factor: 91.245

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.